Ahmad SS, Khan S, Kamal MA, Wasi U (2019) The structure and function of α, β and γ-secretase as therapeutic target enzymes in the development of Alzheimer’s disease: a review. CNS & Neurol Disord-Drug Targets (Formerly Current Drug Targets-CNS Neurol Disord) 18(9):657–667. https://doi.org/10.2174/1871527318666191011145941
Alzheimer’s Association (2014) 2014 Alzheimer’s disease facts and figures. Alzheimer’s Dement 10(2):e47-92. https://doi.org/10.1016/j.jalz.2014.02.001
Arciuch VG, Alippe Y, Carreras MC, Poderoso JJ (2009) Mitochondrial kinases in cell signaling: facts and perspectives. Adv Drug Deliv Rev 61(14):1234–1249. https://doi.org/10.1016/j.addr.2009.04.025
Benítez MJ, Cuadros R, Jiménez JS (2021) Phosphorylation and dephosphorylation of tau protein by the catalytic subunit of PKA, as probed by electrophoretic mobility retard. J Alzheimer’s Dis 79(3):1143–1156. https://doi.org/10.3233/JAD-201077
Bian X, Xue H, Jing D, Wang Y, Zhou G, Zhu F (2023) Role of serum/glucocorticoid-regulated kinase 1 (SGK1) in immune and inflammatory diseases. Inflammation 46(5):1612–1625. https://doi.org/10.1007/s10753-023-01857-8
Article CAS PubMed Google Scholar
Blagov AV, Grechko AV, Nikiforov NG, Borisov EE, Sadykhov NK, Orekhov AN (2022) Role of impaired mitochondrial dynamics processes in the pathogenesis of Alzheimer’s disease. Int J Mol Sci 23(13):6954. https://doi.org/10.3390/ijms23136954
Article CAS PubMed PubMed Central Google Scholar
Bothwell M, Giniger E (2000) Alzheimer’s disease: neurodevelopment converges with neurodegeneration. Cell 102(3):271–273
Article CAS PubMed Google Scholar
Braak H, Del Tredici K (2015) The preclinical phase of the pathological process underlying sporadic Alzheimer’s disease. Brain 138(10):2814–2833. https://doi.org/10.1093/brain/awv236
Breijyeh Z, Karaman R (2020) Comprehensive review on Alzheimer’s disease: causes and treatment. Molecules 25(24):5789. https://doi.org/10.3390/molecules25245789
Article CAS PubMed PubMed Central Google Scholar
Burke RE (2007) Inhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: two approaches with therapeutic potential in the treatment of neurodegenerative disease. Pharmacol Ther 114(3):261–277. https://doi.org/10.1016/j.pharmthera.2007.02.002
Article CAS PubMed PubMed Central Google Scholar
Cao Q, Wang W, Williams JB, Yang F, Wang ZJ, Yan Z (2020) Targeting histone K4 trimethylation for treatment of cognitive and synaptic deficits in mouse models of Alzheimer’s disease. Sci Adv 6(50):eabc8096. https://doi.org/10.1126/sciadv.abc8096
Article CAS PubMed PubMed Central Google Scholar
Casanova A, Wevers A, Navarro-Ledesma S, Pruimboom L (2023) Mitochondria: It is all about energy. Front Physiol 25(14):1114231. https://doi.org/10.3389/fphys.2023.1114231
Catalogna G, Moraca F, D’Antona L, Dattilo V, Perrotti G, Lupia A, Costa G, Ortuso F, Iuliano R, Trapasso F, Amato R (2019) Review about the multi-target profile of resveratrol and its implication in the SGK1 inhibition. Eur J Med Chem 1(183):111675. https://doi.org/10.1016/j.ejmech.2019.111675
Chen J, Stark LA (2017) Aspirin prevention of colorectal cancer: focus on NF-κB signalling and the nucleolus. Biomedicines 5(3):43. https://doi.org/10.3390/biomedicines5030043
Article CAS PubMed PubMed Central Google Scholar
Chen X, Huang J, Yu C, Liu J, Gao W, Li J, Song X, Zhou Z, Li C, Xie Y, Kroemer G (2022) A noncanonical function of EIF4E limits ALDH1B1 activity and increases susceptibility to ferroptosis. Nat Commun 13(1):6318. https://doi.org/10.1038/s41467-022-34096-w
Article CAS PubMed PubMed Central Google Scholar
Chen X, Kang H, Xiao Y (2024) The role of SGK1 in neurologic diseases: A friend or foe? IBRO Neurosci Rep. https://doi.org/10.1016/j.ibneur.2024.12.003
Article PubMed PubMed Central Google Scholar
D’andrea MR (2016) Intracellular consequences of amyloid in Alzheimer’s disease. Academic Press
Das-Earl P, Schreihofer DA, Sumien N, Schreihofer AM (2024) Temporal and region-specific tau hyperphosphorylation in the medulla and forebrain coincides with development of functional changes in male obese Zucker rats. J Neurophysiol 131(4):689–708. https://doi.org/10.1152/jn.00409.2023
Article CAS PubMed PubMed Central Google Scholar
Di Cristofano A (2017) SGK1: the dark side of PI3K signaling. Curr Top Dev Biol 1(123):49–71. https://doi.org/10.1016/bs.ctdb.2016.11.006
DiSabato DJ, Quan N, Godbout JP (2016) Neuroinflammation: the devil is in the details. J Neurochem 139:136–153. https://doi.org/10.1111/jnc.13607
Article CAS PubMed PubMed Central Google Scholar
Du F, Yu Q, Swerdlow RH, Waites CL (2023) Glucocorticoid-driven mitochondrial damage stimulates tau pathology. Brain 146(10):4378–4394. https://doi.org/10.1093/brain/awad127
Article PubMed PubMed Central Google Scholar
Elahi M, Hasan Z, Motoi Y, Matsumoto SE, Ishiguro K, Hattori N (2016) Region-specific vulnerability to oxidative stress, neuroinflammation, and tau hyperphosphorylation in experimental diabetes mellitus mice. J Alzheimer’s Dis 51(4):1209–1224. https://doi.org/10.3233/JAD-150820
Giorgi C, Bouhamida E, Danese A, Previati M, Pinton P, Patergnani S (2021) Relevance of autophagy and mitophagy dynamics and markers in neurodegenerative diseases. Biomedicines 9(2):149. https://doi.org/10.3390/biomedicines9020149
Article CAS PubMed PubMed Central Google Scholar
Gleason CE, Oses-Prieto JA, Li KH, Saha B, Situ G, Burlingame AL, Pearce D (2019) Phosphorylation at distinct subcellular locations underlies specificity in mTORC2-mediated activation of SGK1 and Akt. J Cell Sci 132(7):jcs224931. https://doi.org/10.1242/jcs.224931
Article CAS PubMed PubMed Central Google Scholar
Glosse P (2020) Identification of novel regulators of fibroblast growth factor 23 (FGF23) production: the role of high-fat diet and AMP-activated protein kinase (AMPK) [kumulative Dissertation] Doctoral dissertation. Dissertation, Halle (Saale), Martin-Luther-Universität Halle-Wittenberg
Głowacka P, Oszajca K, Pudlarz A, Szemraj J, Witusik-Perkowska M (2024) Postbiotics as molecules targeting cellular events of aging brain—the role in pathogenesis, prophylaxis and treatment of neurodegenerative diseases. Nutrients 16(14):2244. https://doi.org/10.3390/nu16142244
Article CAS PubMed PubMed Central Google Scholar
Goodfellow VS, Loweth CJ, Ravula SB, Wiemann T, Nguyen T, Xu Y, Todd DE, Sheppard D, Pollack S, Polesskaya O, Marker DF (2013) Discovery, synthesis, and characterization of an orally bioavailable, brain penetrant inhibitor of mixed lineage kinase 3. J Med Chem 56(20):8032–8048. https://doi.org/10.1021/jm401094t
Article CAS PubMed PubMed Central Google Scholar
Greco C (2020) Synthesis and biological evaluation of pyrazolo [3, 4-d] pyrimidine derivatives active as SGK1, Fyn and Src kinases inhibitors. Università degli Studi di Genova
Green KN, Billings LM, Roozendaal B, McGaugh JL, LaFerla FM (2006) Glucocorticoids increase amyloid-β and tau pathology in a mouse model of Alzheimer’s disease. J Neurosci 26(35):9047–9056. https://doi.org/10.1523/jneurosci.2797-06.2006
Article CAS PubMed PubMed Central Google Scholar
Guerriero I, Monaco G, Coppola V, Orlacchio A (2020) Serum and glucocorticoid-inducible kinase 1 (SGK1) in NSCLC therapy. Pharmaceuticals 13(11):413.
Comments (0)